Primary cardiac diffuse large B-cell lymphoma patient: clinical, histologic, immunophenotypic feature and a novel

Chenxi Ying1, Weidong Li1, Yu Zou1

  • 1Department of Cardiovascular Surgery, The First Affiliated Hospital Zhejiang University of Medicine, 79 Qingchun Road, Shangcheng District, Hangzhou City, Zhejiang Province, China.

Insights

A rare cardiac lymphoma case used a novel surgical technique for tumor removal. While initially successful, the aggressive double expressor lymphoma showed disease progression at six months, highlighting treatment challenges.

Area of Science:

  • Cardiology
  • Oncology
  • Surgical Innovation

Background:

  • Primary cardiac lymphoma (PCL) is a rare tumor, with non-germinal center B-cell (non-GCB) diffuse large B-cell lymphoma (DLBCL) posing significant diagnostic and therapeutic challenges.
  • Non-GCB DLBCL often causes severe symptoms due to cardiac involvement.

Observation:

  • A 68-year-old woman presented with palpitations, dizziness, and obstructive cardiac symptoms.
  • Imaging revealed a large right atrial mass near the superior vena cava.
  • A novel "zongzi"-shaped endoscopic gauze folding technique was used for tumor resection.

Findings:

  • Pathology confirmed double expressor DLBCL (BCL2 and MYC co-expression), indicating a high-risk profile.
  • The patient had an uneventful postoperative recovery and was discharged in stable condition.
  • Six-month follow-up revealed local disease progression.

Implications:

  • Novel surgical techniques can aid in complete resection of cardiac tumors while preserving cardiac structure.
  • Aggressive PCL subtypes, like double expressor lymphoma, require further research into optimized multimodal treatment approaches.
  • This case highlights the ongoing challenges in managing primary cardiac DLBCL effectively.
Abstract

Related Concept Videos